Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study
Pharmacology, Toxicology and Pharmaceutical Science
9
6%
Immunology and Microbiology
6
4%
Biochemistry, Genetics and Molecular Biology
4
3%
Other
14
10%
Unknown
58
40%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 November 2024.
All research outputs
#2,109,727
of 34,457,357 outputs
Outputs from Clinical Infectious Diseases
#3,957
of 21,493 outputs
Outputs of similar age
#21,717
of 309,040 outputs
Outputs of similar age from Clinical Infectious Diseases
#50
of 218 outputs
Altmetric has tracked 34,457,357 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 21,493 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.6. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 309,040 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 218 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.
